News & Articles medical prognosis MPI and TD2 join in strategic collaboration to provide drug developers a unique Multi Biomarker direct path to drug ... HOERSHOLM, Denmark and SCOTTSDALE, Ariz. -- Medical Prognosis Institute A/S (MPI) - a Danish company and Translational Drug Development LLC (TD2) based in Scottsdale, Arizona, today announced a strategic ... April 3, 2014 - GlobeNewswire via Yahoo! Finance